Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 13/20 | 0.48 |
| ▸ | DRD2 | P14416 | 10/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
| ▸ | HTR1D | P28221 | 1/20 | 0.43 |
| ▸ | HTR1B | P28222 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30192267 | 0.94 | DRD3 (0.51) | DRD3DRD2DRD4HTR1DHTR1B | |
| SCHEMBL9018959 | 0.81 | DRD3 (0.49) | DRD3DRD2DRD4HTR1DHTR1B | |
| Cyclopropane Carboxylic Acid SCHEMBL17822673 | 0.81 | TAS2R14 (0.48) | DRD3DRD2DRD4HTR1DHTR1B | |
| SCHEMBL7451185 | 0.78 | DRD3 (0.55) | DRD3DRD2DRD4HTR1DHTR1B | |
| SCHEMBL8689595 | 0.78 | DRD3 (0.46) | DRD3DRD2DRD4HTR1DHTR1B | |
| Hydrochloric Acid SCHEMBL7448937 | 0.77 | DRD3 (0.54) | DRD3DRD2DRD4HTR1DHTR1B | |
| SCHEMBL9018943 | 0.75 | DRD3 (0.50) | DRD3DRD2DRD4HTR1DHTR1B | |
| SCHEMBL30705737 | 0.75 | DRD3 (0.50) | DRD3DRD2DRD4HTR1DHTR1B | |
| SCHEMBL9752126 | 0.74 | DRD3 (0.61) | DRD3DRD2DRD4HTR1DHTR1B | |
| SCHEMBL8688537 | 0.74 | DRD3 (0.50) | DRD3DRD2DRD4HTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112500301-B | Regulator for longitudinal behavior | 以西结·戈兰 | 2024-02-13 | — | — | CN | disclosed |
| US-20230092839-A1 | ALCOHOLIC BEVERAGE SUBSTITUTES | Clearmind Medicine Inc. (CA) | 2023-03-23 | — | — | US | disclosed |
| CN-114903134-A | Alcoholic beverage substitute | 以西结·戈兰 | 2022-08-16 | — | — | CN | disclosed |
| CN-114403335-A | Alcoholic beverage substitute | 以西结·戈兰 | 2022-04-29 | — | — | CN | disclosed |
| US-20210330607-A1 | BINGE BEHAVIOR REGULATORS | CLEARMIND LABS CORP. (CA) | 2021-10-28 | — | — | US | disclosed |
| US-11077072-B2 | Binge behavior regulators | Clearmind Medicine Inc. | 2021-08-03 | — | — | US | disclosed |
| CN-112500301-A | Relaxant behavior modulators | 以西结·戈兰 | 2021-03-16 | — | — | CN | disclosed |
| CN-107406369-B | Relaxant behavior modulators | 以西结·戈兰 | 2021-01-15 | — | — | CN | disclosed |
| US-10406123-B2 | Binge behavior regulators | CLEARMIND LABS CORP. (CA) | 2019-09-10 | — | — | US | disclosed |
| US-20190054042-A1 | BINGE BEHAVIOR REGULATORS | CLEARMIND LABS CORP. (CA) | 2019-02-21 | — | — | US | disclosed |
| US-10137096-B2 | Binge behavior regulators | CLEARMIND LABS CORP. (CA) | 2018-11-27 | — | — | US | disclosed |
| US-20180085326-A1 | BINGE BEHAVIOR REGULATORS | CLEARMIND LABS CORP. (CA) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180085326-A1 | BINGE BEHAVIOR REGULATORS | GABRB3, GABRB2, GABRB1 | DRD3 131/4885DRD2 62/4885DRD4 106/4885 |
| US-20230092839-A1 | ALCOHOLIC BEVERAGE SUBSTITUTES | ADH1A, ADH5, ADH1C | DRD3 431/4885DRD2 456/4885DRD4 565/4885 |
| US-10137096-B2 | Binge behavior regulators | GABRB3, GABRB2, GABRB1 | DRD3 131/4885DRD2 62/4885DRD4 106/4885 |
| US-11077072-B2 | Binge behavior regulators | GABRB3, GABRB2, GABRB1 | DRD3 131/4885DRD2 62/4885DRD4 106/4885 |
| US-20190054042-A1 | BINGE BEHAVIOR REGULATORS | GABRB3, GABRB2, GABRB1 | DRD3 131/4885DRD2 62/4885DRD4 106/4885 |
| US-20210330607-A1 | BINGE BEHAVIOR REGULATORS | GABRB3, GABRB2, GABRB1 | DRD3 131/4885DRD2 62/4885DRD4 106/4885 |
| US-10406123-B2 | Binge behavior regulators | GABRB3, GABRB2, GABRB1 | DRD3 131/4885DRD2 62/4885DRD4 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.